NCT02101567View on ClinicalTrials.gov

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

BleedingAnemia

Interventions

DRUG

Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head

In the first group of patients, carbitocin 100 mcg will be given iv infusion over one minute after delivery of the head in cesarean section.

DRUG

Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv

In the second group of patients oxytocin 5 IU will be given iv infusion and Methergine 0.2 mg iv

Trial Locations (1)

Unknown

Nesreen Abdel Fattah Abdullah Shehata, Cairo

All Listed Sponsors

lead

Beni-Suef University

OTHER

NCT02101567 - Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section | Biotech Hunter | Biotech Hunter